
The Silent Killer: Uncontrolled Cardiovascular Risk
Cardiovascular disease (CVD) remains a leading cause of mortality worldwide. Early identification of individuals at high risk is crucial for preventing heart attacks and strokes. However, traditional methods of assessing cardiovascular risk often fall short, leading to delayed interventions and increased morbidity.

The Devastating Impact of Cardiovascular Disease
The consequences of untreated or poorly managed cardiovascular disease are far-reaching. Patients face a heightened risk of heart attacks, strokes, and other life-threatening complications. These events not only impact individuals but also place a significant burden on healthcare systems.

Kribado: Your Partner in Cardiovascular Prevention
Revolutionize Heart Health with Instant Risk Assessment
Kribado is a cutting-edge patient screening solution designed to accurately predict cardiovascular risk. By providing rapid and reliable assessments, Kribado empowers healthcare providers to implement early interventions and improve patient outcomes.
How Kribado Works
- Instant Risk Prediction: Quickly assess a patient’s cardiovascular risk using the Framingham Risk Score.
- Proactive Care: Identify high-risk individuals for timely preventive measures.
- Efficient Workflow Integration: Seamlessly integrate cardiovascular risk assessment into your practice.
- Data-Driven Decisions: Make informed decisions based on accurate and actionable insights.

Trusted by Pharmaceutical Leaders
Indigital Technologies LLP is a pioneer in pharmaceutical business growth. With a proven track record of delivering innovative solutions, we are committed to improving patient care and driving industry progress.
- Highlight key achievements: Mention number of pharmaceutical brands worked with, revenue generated, patents, and customer satisfaction ratings.
- Showcase expertise: Emphasize experience in working with various therapeutic areas and developing risk scores.